Emile de Heer

11.2k total citations · 1 hit paper
204 papers, 8.5k citations indexed

About

Emile de Heer is a scholar working on Nephrology, Immunology and Molecular Biology. According to data from OpenAlex, Emile de Heer has authored 204 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Nephrology, 51 papers in Immunology and 50 papers in Molecular Biology. Recurrent topics in Emile de Heer's work include Renal Diseases and Glomerulopathies (54 papers), Renal and related cancers (26 papers) and Cell Adhesion Molecules Research (25 papers). Emile de Heer is often cited by papers focused on Renal Diseases and Glomerulopathies (54 papers), Renal and related cancers (26 papers) and Cell Adhesion Molecules Research (25 papers). Emile de Heer collaborates with scholars based in Netherlands, United States and Germany. Emile de Heer's co-authors include Jan A. Bruijn, Hans J. Baelde, Dorien J.M. Peters, Ingeborg M. Bajema, Michael Eikmans, Wouter N. Leonhard, Antien L. Mooyaart, Martijn H. Breuning, Jan A. Bruijn and Annemieke van der Wal and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Emile de Heer

203 papers receiving 8.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pathologic Classification of Diabetic Nephropathy

2010 1.2k citations Cinthia B. Drachenberg, Emile de Heer et al. Journal of the American Society of Nephrology profile →

Peers

Countries citing papers authored by Emile de Heer

Since Specialization

Citations

This map shows the geographic impact of Emile de Heer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emile de Heer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emile de Heer more than expected).

Fields of papers citing papers by Emile de Heer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emile de Heer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emile de Heer. The network helps show where Emile de Heer may publish in the future.

Co-authorship network of co-authors of Emile de Heer

This figure shows the co-authorship network connecting the top 25 collaborators of Emile de Heer. A scholar is included among the top collaborators of Emile de Heer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emile de Heer. Emile de Heer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Analysis of the genomic architecture of a complex trait locus in hypertensive rat models links Tmem63c to kidney damage 2019 ·eLife ·Angela Schulz, (unknown), (unknown), Andreas Eisenreich, (unknown), Andrei Barysenka, Bettina Purfürst, Anje Sporbert, (unknown), (unknown), (unknown), Anika Witten, Frank Rühle, Weibin Zhou, Emile de Heer, Marion Scharpfenecker, Daniela Panáková, Monika Stoll, Reinhold Kreutz	23
2	Diagnosis of Early Pancreas Graft Failure via Antibody-Mediated Rejection: Single-Center Experience With 256 Pancreas Transplantations 2014 ·American Journal of Transplantation ·Hanneke de Kort, Marko J.K. Mallat, Cees van Kooten, Emile de Heer, (unknown), A M van der Wal, Candice Roufosse, Dave L. Roelen, Jan A. Bruijn, Frans H.J. Claas, Johan W. de Fijter, Ingeborg M. Bajema	17
3	Renal Ischemia/Reperfusion Induces Release of Angiopoietin-2 from Human Grafts of Living and Deceased Donors 2013 ·American Journal of Transplantation ·Marlies E. J. Reinders, (unknown), Meriem Khairoun, J. Lindeman, Ingeborg M. Bajema, Emile de Heer, Mark Roest, Anton Jan van Zonneveld, Cees van Kooten, Alexander F. Schaapherder, Ton J. Rabelink	2
4	Pregnancy Close to the Edge: An Immunosuppressive Infiltrate in the Chorionic Plate of Placentas from Uncomplicated Egg Cell Donation 2012 ·PLoS ONE ·Dorrith Schonkeren, Godelieve M.J.S. Swings, Drucilla J. Roberts, Frans H.J. Claas, Emile de Heer, Sicco A. Scherjon	29
5	Differential Distribution and Phenotype of Decidual Macrophages in Preeclamptic versus Control Pregnancies 2011 ·American Journal Of Pathology ·Dorrith Schonkeren, Marie‐Louise van der Hoorn, Padmini P. S. J. Khedoe, Godelieve M.J.S. Swings, Els van Beelen, Frans H.J. Claas, Cees van Kooten, Emile de Heer, Sicco A. Scherjon	149
6	Epac-Rap Signaling Reduces Cellular Stress and Ischemia-induced Kidney Failure 2011 ·Journal of the American Society of Nephrology ·Geurt Stokman, Yu Qin, Hans‐Gottfried Genieser, Frank Schwede, Emile de Heer, Johannes L. Bos, Ingeborg M. Bajema, Bob van de Water, Leo Price	34
7	Pancreas Allograft Biopsies with Positive C4d Staining and Anti‐Donor Antibodies Related to Worse Outcome for Patients 2010 ·American Journal of Transplantation ·Hanneke de Kort, Raghava Munivenkatappa, Stefan P. Berger, Michael Eikmans, Annemieke van der Wal, Eelco J.P. de Koning, Cees van Kooten, Emile de Heer, Rolf N. Barth, Jan A. Bruijn, Benjamin Philosophe, Cinthia B. Drachenberg, Ingeborg M. Bajema	35
8	Early Renal Ischemia-Reperfusion Injury in Humans Is Dominated by IL-6 Release from the Allograft 2009 ·American Journal of Transplantation ·Dorottya K. de Vries, J. Lindeman, Dimitrios Tsikas, Emile de Heer, A. Roos, Johan W. de Fijter, Andrzej Baranski, Jos van Pelt, Alexander F. Schaapherder	56
9	Identification of a human CD8 ⁺ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4 2007 ·Proceedings of the National Academy of Sciences ·Simone A. Joosten, Krista E. van Meijgaarden, Nigel D. L. Savage, Tjitske de Boer, Frédéric Triebel, Annemieke van der Wal, Emile de Heer, Michèl R. Klein, Annemieke Geluk, Tom H. M. Ottenhoff	157
10	Hypotheses on the Etiology of Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis 2007 ·Clinical Journal of the American Society of Nephrology ·Robert A.F. de Lind van Wijngaarden, (unknown), E. Christiaan Hagen, Richard A. Watts, Gina Gregorini, Jan Willem Cohen Tervaert, Alfred Mahr, John L. Niles, Emile de Heer, Jan A. Bruijn, Ingeborg M. Bajema	69
11	The use of extracellular matrix probes and extracellular matrix-related probes for assessing diagnosis and prognosis in renal diseases 2004 ·Current Opinion in Nephrology & Hypertension ·Michael Eikmans, Daphne H.T. IJpelaar, Hans J. Baelde, Emile de Heer, Jan A. Bruijn	1
12	Altered distribution and co-localization of polycystin-2 with polycystin-1 in MDCK cells after wounding stress 2003 ·Experimental Cell Research ·(unknown), (unknown), (unknown), (unknown), Martijn H. Breuning, Emile de Heer, Dorien J.M. Peters	16
13	Nitric oxide synthase isoform expression in acute versus chronic anti-Thy 1 nephritis 2002 ·Kidney International ·Markus Ketteler, Ralf Westenfeld, Alexander Gawlik, Sebastian Bachmann, Alexander D. Frey, Gilbert Schönfelder, Martin Paul, Armin Distler, Emile de Heer	14
14	Fibronectin accumulation in glomerulosclerotic lesions: Self-assembly sites and the heparin II binding domain 2002 ·Kidney International ·(unknown), (unknown), Hans J. Baelde, Emile de Heer, Jan A. Bruijn	15
15	High transforming growth factor-?? and extracellular matrix mRNA response in renal allografts during early acute rejection is associated with absence of chronic rejection1 2002 ·Transplantation ·Michael Eikmans, Yvo W.J. Sijpkens, Hans J. Baelde, Emile de Heer, Lorna Paul, Jan A. Bruijn	47
16	Effect of age and biopsy site on extracellular matrix mRNA and protein levels in human kidney biopsies 2001 ·Kidney International ·Michael Eikmans, Hans J. Baelde, Emile de Heer, Jan A. Bruijn	28
17	Remodeling of the porcine pulmonary autograft wall in the aortic position 2000 ·Journal of Thoracic and Cardiovascular Surgery ·Paul H. Schoof, Adriana C. Gittenberger–de Groot, Emile de Heer, Jan A. Bruijn, Mark G. Hazekamp, Hans A. Huysmans	30
18	Processing Renal Biopsies for Diagnostic mRNA Quantification 2000 ·Journal of the American Society of Nephrology ·Michael Eikmans, Hans J. Baelde, Emile de Heer, Jan A. Bruijn	29
19	Association between leukocyte infiltration and development of glomerulosclerosis in experimental lupus nephritis 1998 ·The Journal of Pathology ·(unknown), (unknown), Hans J. Baelde, Emile de Heer, (unknown)	9
20	Applications in renal immunopathology of reflection contrast microscopy, a novel superior light microscopical technique 1996 ·Kidney International ·Frans A. Prins, Jan A. Bruijn, Emile de Heer	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact